Kent Winger - Vasamed VP
VSMD Stock | USD 0.0001 0.00 0.00% |
VP
Kent Winger was our Vice PresidentOperations of Optical Sensors since January 2006. From February 2000 through January 2006, Mr. Winger was Director of Operations of the Company. Prior to that, Mr. Winger had been the Manager of Operations since June 1999 and joined us in February 1998 as our Engineering Manager. Prior to joining company Mr. Winger had been the Manager of Operations, Cardiology Division at Boston Scientific Corporation since 1991. since 2006.
Age | 51 |
Tenure | 18 years |
Phone | 952-944-5857 |
Web | https://www.vasamed.com |
Vasamed Management Efficiency
The company has return on total asset (ROA) of (0.741) % which means that it has lost $0.741 on every $100 spent on assets. This is way below average. Vasamed's management efficiency ratios could be used to measure how well Vasamed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 4 records | VP Age | ||
Timothy Duffy | Teleflex Incorporated | N/A | |
Meghan Elliott | Apogee Enterprises | 47 | |
Gary Johnson | Apogee Enterprises | 55 | |
Jake Elguicze | Teleflex Incorporated | 42 |
Management Performance
Return On Asset | -0.74 |
Vasamed Leadership Team
Elected by the shareholders, the Vasamed's board of directors comprises two types of representatives: Vasamed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vasamed. The board's role is to monitor Vasamed's management team and ensure that shareholders' interests are well served. Vasamed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vasamed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Terry Duesterhoeft, Vice President of Sales and Marketing | ||
Andrew Jay, Director | ||
Michael Schreiber, Pres CEO | ||
Roberta Dircks, CFO and VP of Fin. and Admin. | ||
Wesley Peterson, Sec | ||
Daniel Bartnik, CTO Operations | ||
Paulita LaPlante, CEO and President and Director | ||
Charles Snead, Director | ||
Kent Winger, VP of Operations and VP of Strategic Planning and Product Devel. | ||
Richard Egen, Director | ||
Craig Walker, Director |
Vasamed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Vasamed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.74 | |||
Profit Margin | (0.56) % | |||
Operating Margin | (0.47) % | |||
Current Valuation | 2.89 M | |||
Shares Owned By Institutions | 0.30 % | |||
Price To Earning | (0.33) X | |||
Price To Sales | 0.84 X | |||
Revenue | 3.13 M | |||
Gross Profit | 1.73 M | |||
EBITDA | (1.47 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.CLSK | CleanSpark | |
V | Visa Class A | |
CDLX | Cardlytics |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vasamed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Vasamed Pink Sheet analysis
When running Vasamed's price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |